SZSE:300254 (China)
Â
Class A
Â¥
7.69
(-1.03%)
Jul 16
New Key Statistics Module, Z-Score and F-Score
SZSE:300254 Key Ratios
| Market Cap ¥ M | 1,858.05 |
| Enterprise Value ¥ M | 2,159.90 |
| P/E(ttm) | 40.69 |
| PE Ratio without NRI | 58.26 |
| Forward PE Ratio | -- |
| Price/Book | 3.00 |
| Price/Sales | 2.30 |
| Price/Free Cash Flow | 384.50 |
| Price/Owner Earnings | 167.19 |
| Payout Ratio % | -- |
| Revenue (TTM) ¥ M | 805.00 |
| EPS (TTM) ¥ | 0.19 |
| Beneish M-Score | -2.18 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 21.15 |
| EV-to-EBITDA | 21.15 |
| PEG | -- |
| Shares Outstanding M | 241.62 |
| Net Margin (%) | 5.67 |
| Operating Margin % | 5.86 |
| Pre-tax Margin (%) | 9.48 |
| Quick Ratio | 0.65 |
| Current Ratio | 0.93 |
| ROA % (ttm) | 2.96 |
| ROE % (ttm) | 7.86 |
| ROIC % (ttm) | 3.27 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.22 |
SZSE:300254 Number of Guru Trades
SZSE:300254 Volume of Guru Trades
Gurus Latest Trades with SZSE:300254
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300254 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanxi C&Y Pharmaceutical Group Co Ltd Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers